Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis

Update Il y a 4 ans
Reference: NCT00279760

Woman and Man

Extract

This randomized, double-blind, placebo controlled, parallel and multiple dose study provided safety, preliminary efficacy, and immunogenicity information about the use of BMS-188667 and BMS-224818 in subjects with RA


Inclusion criteria

  • Rheumatoid Arthritis


Links